Question follow-through · 63299
Selective Serotonin Reuptake Inhibitors: Packaging
To ask the Secretary of State for Health and Social Care, when he plans to publish the report on packaging changes to Selective serotonin reuptake inhibitors, as discussed at the Commission on Human Medicines Antidepressant Risk Minimisation Expert Workin
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 27 Jun 2025
- Target answer date
- 1 Jul 2025
- Answer
- 4 Jul 2025 · 7 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Patient Safety Commissioner · 10 Jul 2025
- Zoe Marketing & Communications · 16 Jul 2025
- Primodos: Civil Proceedings · 17 Jul 2025
- Chiropractic · 29 Aug 2025
- Chiropractic · 29 Aug 2025
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
27 Jun 2025
Question tabled
To ask the Secretary of State for Health and Social Care, when he plans to publish the report on packaging changes to Selective serotonin reuptake inhibitors, as discussed at the Commission on Human Medicines Antidepressant Risk Minimisation Expert Workin
1 Jul 2025
Target answer date
Date supplied by the official written-questions record.
4 Jul 2025
Answer published
A public assessment report will be published by the Medicines and Healthcare products Regulatory Agency (MHRA) after the completion of the review. The advice of the Commission on Human Medicines (CHM) will be sought after the next meeting of the Antidepre...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Patient Safety Commissioner
10 Jul 2025 · To ask the Secretary of State for Health and Social Care, with reference to page 94 of his Department's policy paper entitled Fit for the future: 10 year health plan for England, published in July 2025, what assessment he has made of the potential impact
Zoe Marketing & Communications
16 Jul 2025 · To ask the Secretary of State for Health and Social Care, with reference to the FOI request 2024/00205, when the Medicines and Healthcare products Regulatory Agency plans to publish (a) details of its investigation into the advertising activities of the c
Primodos: Civil Proceedings
17 Jul 2025 · To ask the Secretary of State for Health and Social Care, what litigation costs his Department incurred in Wilson and others v Bayer Pharma and others, [2023] EWHC 1282 (QB); and how many representatives of his Department attended the Royal Courts of Just
Chiropractic
29 Aug 2025 · To ask the Secretary of State for Health and Social Care, if his Department will (a) support further integration of chiropractic care into NHS services across Tatton and (b) give chiropractors Allied Healthcare Professional status.
Chiropractic
29 Aug 2025 · To ask the Secretary of State for Health and Social Care, if his Department will consider reviewing the Allied Healthcare Professional status list to include chiropractors as part of the government’s wider review of the NHS.
Vaccine Damage Payment Scheme: Appeals
3 Sept 2025 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 March 2025 to Question 34608 on Vaccine Damage Payment Scheme: Appeals, whether past tribunal decisions are used to support assessments.
Coronavirus: Vaccination
10 Sept 2025 · To ask the Secretary of State for Health and Social Care, how much funding his department allocated to the indemnity schemes in place for Covid-19 vaccinations.
Mental Health Services: Children
10 Oct 2025 · To ask the Secretary of State for Health and Social Care, with reference to FOI request 24/015 to the Medicines and Healthcare products Regulatory Agency, if he will publish the responses received from the Swedish Medical Products Agency following their o
Vaccine Damage Payment Scheme: Coronavirus
29 Oct 2025 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 7 July 2025 to Question 64393 on Vaccine Damage Payment Scheme: Coronavirus, what steps he is taking to improve the Vaccine Damage Payment Scheme.
Selective Serotonin Reuptake Inhibitors: Packaging
10 Dec 2025 · To ask the Secretary of State for Health and Social Care, pursuant to the answer of 4 July 2025 to question 63299, when he plans to publish the report on packaging changes to Selective serotonin reuptake inhibitors, as discussed at the Commission on Human
Visual Snow Syndrome: Yellow Card Scheme
10 Dec 2025 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer 1 December 2025 to Question HL12274 on Visual Snow Syndrome: Yellow Card Scheme, if he will confirm whether official UK drug labels or patient information leaflets warn about
Coronavirus: Research
15 Jan 2026 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 23 June 2025 to Question 59379 on Coronavirus: Research, and with reference to FOI 15/11/25/IR/575, when the UKHSA expects to receive the report from (a) Moderna and (b) P